Clinical Significance of Thyroid Autoantibodies in Differential Diagnosis and Predicting the Course of Programmed Cell Death Protein-1 Inhibitor-Induced Thyroid Dysfunction
Authors' conclusion
In patients with thyrotoxicosis caused by PD-1 inhibitors, serum TgAb, and TPOAb levels can be used to distinguish between primary hyperthyroidism and destructive thyroiditis. This study provides insights into novel treatment targets and effective management strategies for PD-1-induced thyrotoxicosis.
Study context
- Population
- Patients with thyroid dysfunction who received PD-1 inhibitors at one hospital, January 2022–June 2024plus 42 controls
- Participants
- 161 patients
- Exposure
- Thyroid autoantibody positivity across PD-1 inhibitor-induced thyroid dysfunction types; PD-1-induced destructive thyroiditis vs Hashimoto's thyroiditis
- Hashimoto's thyroiditisn = 42reference
- Outcome
- Thyroid autoantibody positivity
Methodological detailssingle-centre
- Single-centre
Main finding
As reported in the abstract
| Group | Value | TPOAb-positive cases | TPOAb or TgAb positivity rate |
|---|---|---|---|
| Primary hypothyroidism | 1 events | 1 | |
| Destructive thyroiditis | 92.9% | 92.9% |
Value
Primary hypothyroidism1 events
Destructive thyroiditis92.9%
TPOAb-positive cases
Primary hypothyroidism1
Destructive thyroiditis— not stated in the abstract
TPOAb or TgAb positivity rate
Primary hypothyroidism— not stated in the abstract
Destructive thyroiditis92.9%
Observational data: associations, not effects.
Further findings
Age, sex and time from thyrotoxicosis to hypothyroidism, destructive thyroiditis vs Hashimoto's thyroiditis
- Statistically significant differences in age, sex and time from thyrotoxicosis to hypothyroidism
Original publication
Clinical Significance of Thyroid Autoantibodies in Differential Diagnosis and Predicting the Course of Programmed Cell Death Protein-1 Inhibitor-Induced Thyroid Dysfunction. Endocr Pract. Published 30 August 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →